Recent studies have shown that abnormal expression of Claudin family proteins as a key component of TJs is closely related to the occurrence, development, and prognosis of tumors, making them ideal therapeutic targets with high potential. Download this white paper and learn more about the newly launched FLAG Claudin Family Proteins facilitate innovative drug development.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.